Enterprise Products
SIMSON PHARMA LIMITED, India, manufactures and sells Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. Their product portfolio encompasses a wide range of APIs used in various therapeutic areas.
Some of their key Active Pharmaceutical Ingredients include:
Dapoxetine Hydrochloride, Dutasteride, Finasteride, Minoxidil, Sildenafil Citrate, Tadalafil, Vardenafil Hydrochloride, Avanafil, Flibanserin, Ruxolitinib, Lurasidone Hydrochloride, Apixaban, Sacubitril, Valganciclovir, Sofosbuvir, Ledipasvir, Velpatasvir, Daclatasvir, Entecavir, Tenofovir Disoproxil Fumarate, Abiraterone Acetate, Enzalutamide, Palbociclib, Ibrutinib, Acalabrutinib, Osimertinib, Brigatinib, Neratinib, Lorlatinib, Pomalidomide, Lenalidomide, Ixazomib Citrate, Carfilzomib, Bortezomib, Cabozantinib, Regorafenib, Sorafenib, Axitinib, Sunitinib Malate, Pazopanib Hydrochloride, Lenvatinib Mesylate, Nintedanib Esylate, Crizotinib, Ceritinib, Alectinib Hydrochloride, Erlotinib Hydrochloride, Afatinib Dimaleate, Gefitinib, Lapatinib Ditosylate, Everolimus, Sirolimus, Temsirolimus, Midostaurin, Gilteritinib Fumarate, Venetoclax, Glasdegib Maleate, Sonidegib Phosphate, Vismodegib, Tofacitinib Citrate, Baricitinib, Upadacitinib, Filgotinib, Peficitinib, Ozanimod Hydrochloride, Siponimod Fumarate, Ponesimod, Fingolimod Hydrochloride, Teriflunomide, Dimethyl Fumarate, Cladribine, Glatiramer Acetate, Interferon Beta-1a, Interferon Beta-1b, Peginterferon Beta-1a, Fampridine, and Dalfampridine, among many others.
They also provide pharmaceutical intermediates essential for the synthesis of these APIs.